Calliditas Therapeutics: Q2 Earnings Insights

Calliditas Therapeutics (NASDAQ:CALT) reported its Q2 earnings results on Thursday, August 18, 2022 at 01:00 AM. Here's what investors need to know about the announcement.

byBenzinga Insights

August 18, 2022

1 minute read

Calliditas Therapeutics (NASDAQ:CALT) reported its Q2 earnings results on Thursday, August 18, 2022 at 01:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Calliditas Therapeutics beat estimated earnings by 26.3%, reporting an EPS of $-0.737 versus an estimate of $-1.0.

Revenue was up $6.51 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 15.45% increase in the share price the next day.

To track all earnings releases for Calliditas Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

IsoPlexis Announces Preliminary Unaudited Revenue For The Full Year Ended Dec 31, 2022 Total Revenue To Be In The Range Of $16.6M-$16.8M, Down 3%-4% YoY; Q4 Results Were Lower Than Expected Primarily Due To The Timing Of Customer Orders For Instruments

By Benzinga Newsdesk

January 12, 5:07 PM

IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary unaudited revenue for the full year ended

ISO

Earnings

Earnings Outlook For Gorman-Rupp

By Benzinga Insights

October 27, 12:16 PM

Gorman-Rupp (NYSE:GRC) is set to give its latest quarterly earnings report on Friday, 2022-10-28. Here's what investors need to know before the announcement. Analysts estimate that Gorman-Rupp will report an earnings per share (EPS) of $0.36.

GRC